Corion Biotech

Innovative therapies for women's health

CEO & Co-founder: Carlo Cavallero
CSO & Co-founder: Alessandro Rolfo
CMO & Co-founder: Tullia Todros
Project Manager: Elena Dragomir

Corion Biotech develops innovative organic medicines derived from human placenta and aimed at therapeutic interventions for women's health. In particular, it is perfecting the world's first specific therapy against pre-eclampsia, a human pregnancy syndrome that affects about 7 million pregnant women every year and represents one of the main causes of maternal-fetal mortality worldwide.


Year of establishment: 2012

Employees: 1-5

The product/service is already on the market? No

Investments received: € 1,000,000 Venture Capital

Contest: StartCup

Incubation/acceleration programme: -

Discover others Startup
Are you part of the Corion Biotech team? To make changes to this sheet contact us at: